Nuclear-Targeting MSNs-Based Drug Delivery System: Global Gene Expression Analysis on the MDR-Overcoming Mechanisms (Q38829287)

6 September 2017

Nuclear-Targeting MSNs-Based Drug Delivery System: Global Gene Expression Analysis on the MDR-Overcoming Mechanisms (English)

1 reference

6 September 2017

1 reference

Xiaoyu Li

1

1 reference

PubMed ID

26450832

6 September 2017

Limin Pan

series ordinal

2

1 reference

PubMed ID

26450832

6 September 2017

Jianlin Shi

series ordinal

3

1 reference

6 September 2017

9 October 2015

1 reference

Advanced Healthcare Materials

6 September 2017

1 reference

6 September 2017

4

1 reference

6 September 2017

17

1 reference

6 September 2017

2641-2648

1 reference

Multi-drug resistance in cancer chemotherapeutics: mechanisms and lab approaches

6 September 2017

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201500548

PI3KCA plays a major role in multiple myeloma and its inhibition with BYL719 decreases proliferation, synergizes with other therapies and overcomes stroma-induced resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201500548

DNA damage and repair in human cancer: molecular mechanisms and contribution to therapy-related leukemias.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201500548

Integrated epigenomics identifies BMP4 as a modulator of cisplatin sensitivity in gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201500548

Drug resistance: still a daunting challenge to the successful treatment of AML.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201500548

A role for activator of G-protein signaling 3 (AGS3) in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201500548

Phytochemicals as chemosensitizers: from molecular mechanism to clinical significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201500548

MicroRNA-19a/b regulates multidrug resistance in human gastric cancer cells by targeting PTEN.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201500548

Identification of cancer stem cells in vincristine preconditioned SGC7901 gastric cancer cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201500548

Nanoparticles in cancer therapy and diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201500548

Mechanisms of antifolate resistance and methotrexate efficacy in leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201500548

Controlled intracellular release of doxorubicin in multidrug-resistant cancer cells by tuning the shell-pore sizes of mesoporous silica nanoparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201500548

Sequential treatment of drug-resistant tumors with RGD-modified liposomes containing siRNA or doxorubicin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201500548

A pH-responsive mesoporous silica nanoparticles-based multi-drug delivery system for overcoming multi-drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201500548

MSN-mediated sequential vascular-to-cell nuclear-targeted drug delivery for efficient tumor regression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201500548

Extension of the Stöber method to construct mesoporous SiO2 and TiO2 shells for uniform multifunctional core-shell structures

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201500548

Hybrid nanoparticles for drug delivery and bioimaging: mesoporous silica nanoparticles functionalized with carboxyl groups and a near-infrared fluorescent dye.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201500548

An anticancer drug delivery system based on surfactant-templated mesoporous silica nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201500548

Mesoporous silica-coated gold nanorods as a light-mediated multifunctional theranostic platform for cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201500548

Overcoming multidrug resistance of cancer cells by direct intranuclear drug delivery using TAT-conjugated mesoporous silica nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201500548

Downregulation of Bcl-xL and activation of caspases during retinoic acid-induced apoptosis in an adult T-cell leukemia cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201500548

Emetine regulates the alternative splicing of Bcl-x through a protein phosphatase 1-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201500548

Biology of the multidrug resistance-associated protein, MRP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201500548

Major vault protein LRP-related multidrug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201500548

The clinical manifestation of a defective response to DNA double-strand breaks as exemplified by Nijmegen breakage syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201500548

Emerging cancer therapeutic opportunities target DNA-repair systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201500548

Drug resistance and DNA repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201500548

Role of RAD51C and XRCC3 in genetic recombination and DNA repair.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201500548

Involvement of Rad51 in cytotoxicity induced by epidermal growth factor receptor inhibitor (gefitinib, IressaR) and chemotherapeutic agents in human lung cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201500548

Brca2/Xrcc2 dependent HR, but not NHEJ, is required for protection against O(6)-methylguanine triggered apoptosis, DSBs and chromosomal aberrations by a process leading to SCEs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201500548

p53: a guide to apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201500548

WAF1, a potential mediator of p53 tumor suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201500548

21 January 2018

Surfing the p53 network

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201500548

21 January 2018

Identifiers

DOI

10.1002/ADHM.201500548

1 reference

6 September 2017

1 reference

PubMed ID

26450832